VCAM-1 was expressed in 0.9% of CD3+ T cells overall, and in tumour and stromal compartments in 0.4% (range 0.1–7.4%) and 1.0% (range 0.1–8.1%) of CD3+ T cells respectively. The gene discussed is VCAM1; the disease is neoplasm.